Home » Topics » BioWorld Science

BioWorld Science
RSS

Ideaya reports preliminary phase I/II data on darovasertib in metastatic uveal melanoma

April 16, 2021

Aussie researchers show critical role of DC-SCRIPT in producing key dendritic immune cells

April 16, 2021

Phase II trial of TQ-B3525 for advanced gynecological cancers begins enrollment

April 16, 2021

Yale begins phase I study of BMS-984923 for Alzheimer's disease

April 16, 2021

Discovery of allosteric MALT1 protease inhibitor JNJ-67856633 for cancer

April 16, 2021

Enrollment opens in phase Ib study of RO-7122290 with cibisatamab in colorectal cancer

April 16, 2021

Praxis initiates phase II/III trial of PRAX-114 for major depressive disorder

April 16, 2021

Icatibant portion of I-SPY COVID trial ends after futility criterion met

April 16, 2021

JNJ-74856665 mediates potent antileukemic activity and differentiation in preclinical models

April 16, 2021

New conjugated chimeric proteins presented by Orionis Biosciences

April 16, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...